Yamazaki, H <br/><br/>
Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes.  [electronic resource] 

 -  Carcinogenesis  Sep 1995 
 - 2167-70 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0143-3334 
<br/><br/><label>Standard No.: </label>10.1093/carcin/16.9.2167  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibody Specificity<br/>Biotransformation<br/>Carcinogens--pharmacokinetics<br/>Cytochrome P-450 CYP3A<br/>Cytochrome P-450 Enzyme System--genetics<br/>DNA, Complementary--genetics<br/>Escherichia coli--enzymology<br/>Heterocyclic Compounds--pharmacokinetics<br/>Humans<br/>Immunoblotting<br/>Isoenzymes--genetics<br/>Microsomes, Liver--enzymology<br/>Mixed Function Oxygenases--genetics<br/>Mycotoxins--pharmacokinetics<br/>Polycyclic Aromatic Hydrocarbons--pharmacokinetics<br/>Prodrugs--pharmacokinetics<br/>Recombinant Proteins--genetics<br/>Salmonella typhimurium--drug effects